These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32033577)

  • 1. Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance.
    Smits RM; Veldhuijzen DS; van Middendorp H; Hissink Muller PCE; Armbrust W; Legger E; Wulffraat NM; Evers AWM
    Pediatr Rheumatol Online J; 2020 Feb; 18(1):12. PubMed ID: 32033577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
    Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of Methotrexate Intolerance and Its Impact on Daily Life in School-Age Children with Juvenile Idiopathic Arthritis.
    Khan S; Mancini J; Hopper C; Rennick JE
    J Pediatr Nurs; 2019; 48():49-54. PubMed ID: 31254860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing - treatment protocol and preliminary results.
    Höfel L; Eppler B; Storf M; Schnöbel-Müller E; Haas JP; Hügle B
    Pediatr Rheumatol Online J; 2018 Feb; 16(1):11. PubMed ID: 29433504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting.
    Ferrara G; Mastrangelo G; Barone P; La Torre F; Martino S; Pappagallo G; Ravelli A; Taddio A; Zulian F; Cimaz R;
    Pediatr Rheumatol Online J; 2018 Jul; 16(1):46. PubMed ID: 29996864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.
    van Dijkhuizen EH; Wulffraat NM
    Pediatr Rheumatol Online J; 2014; 12():51. PubMed ID: 25525416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis.
    Scheuern A; Fischer N; McDonald J; Brunner HI; Haas JP; Hügle B
    Pediatr Rheumatol Online J; 2016 Feb; 14(1):11. PubMed ID: 26928923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study.
    van der Meer A; Wulffraat NM; Prakken BJ; Gijsbers B; Rademaker CM; Sinnema G
    Clin Exp Rheumatol; 2007; 25(3):480-5. PubMed ID: 17631750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children.
    Kyvsgaard N; Mikkelsen TS; Thastum M; Christensen AE; Wehner PS; Nysom K; Herlin T
    PLoS One; 2019; 14(7):e0219539. PubMed ID: 31295288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration.
    Fráňová J; Fingerhutová Š; Kobrová K; Srp R; Němcová D; Hoza J; Uher M; Saifridová M; Linková L; Doležalová P
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):36. PubMed ID: 27301536
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Roszkiewicz J; Michałek D; Ryk A; Swacha Z; Szmyd B; Smolewska E
    Scand J Rheumatol; 2021 May; 50(3):213-217. PubMed ID: 33025831
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methotrexate in the therapy of juvenile idiopathic arthritis].
    Holzinger D; Frosch M; Föll D
    Z Rheumatol; 2010 Aug; 69(6):496-504. PubMed ID: 20632181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate in juvenile idiopathic arthritis: towards tailor-made treatment.
    Ćalasan MB; Wulffraat NM
    Expert Rev Clin Immunol; 2014 Jul; 10(7):843-54. PubMed ID: 24857620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of methotrexate in children with rheumatic diseases.
    Gutiérrez-Suárez R; Burgos-Vargas R
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTX intolerance in children and adolescents with juvenile idiopathic arthritis.
    Hügle B; van Dijkhuizen EHP
    Rheumatology (Oxford); 2020 Jul; 59(7):1482-1488. PubMed ID: 32259834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of methotrexate in juvenile idiopathic arthritis.
    Ramanan AV; Whitworth P; Baildam EM
    Arch Dis Child; 2003 Mar; 88(3):197-200. PubMed ID: 12598376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Satisfaction With and Adherence to Disease-Modifying Antirheumatic Drugs in Adult Patients With Juvenile Idiopathic Arthritis.
    Tollisen A; Flatø B; Selvaag AM; Aasland A; Ingebrigtsen T; Sagen J; Lerdal A
    Arthritis Care Res (Hoboken); 2021 Feb; 73(2):221-231. PubMed ID: 31758669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis.
    Kyvsgaard N; Mikkelsen TS; Als TD; Christensen AE; Corydon TJ; Herlin T
    Pediatr Rheumatol Online J; 2021 Apr; 19(1):51. PubMed ID: 33794950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?
    Roszkiewicz J; Smolewska E
    Curr Rheumatol Rep; 2017 Apr; 19(4):19. PubMed ID: 28361333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MTX intolerance in children and adolescents with juvenile idiopathic arthritis].
    Hügle B
    Z Rheumatol; 2019 Sep; 78(7):620-626. PubMed ID: 31065791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.